Acetylcholine Release at the Neuromuscular Junction (ACh Release (NMJ))

Acetylcholine (ACh) release at the neuromuscular junction is the process by which a motor neuron communicates with a skeletal muscle fiber to initiate muscle contraction. This involves the influx of calcium ions into the presynaptic terminal of the motor neuron, leading to the fusion of acetylcholine-containing vesicles with the presynaptic membrane and the subsequent release of ACh into the synaptic cleft. ACh then binds to nicotinic acetylcholine receptors (nAChRs) on the muscle fiber, triggering depolarization and muscle contraction. The process is terminated by acetylcholinesterase, which breaks down ACh in the synaptic cleft.

Other names

Acetylcholine ExocytosisNeuromuscular TransmissionMotor Neuron SignalingACh Release at NMJ

Drugs can affect ACh release by modulating calcium channel activity (e.g., magnesium) or interfering with SNARE protein function (e.g., botulinum toxin). Cholinesterase inhibitors prolong ACh action by preventing its degradation, indirectly affecting the overall process.